Bottom line
BGEAX vs URTH: the short answer
BGEAX (Brandes Global Equity Fund) and URTH (iShares MSCI World ETF) are both mutual funds.
But URTH is far broader, holding 1,329 positions to 69 for BGEAX, so beyond the top names it adds exposure BGEAX doesn't have.
URTH is cheaper at 0.24% vs 1.2% — a difference of $96 a year per $10,000 invested.
Over five years, BGEAX returned +14.2% a year vs +11.3% for URTH (reporting dates differ).
BGEAX has a front-end sales load of up to 5.75%; the other does not.
Updated Nov 19, 2026
BGEAX vs URTH side by side
| BGEAX | URTH | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Datum One | iShares |
| Category | Global Stock | Global Stock |
| Expense ratio | 1.2% | 0.24% |
| Annual cost per $10k | $120 | $24 |
| 10-yr cost on $10k (prospectus) | $2,093 | $306 |
| Max front load | 5.75% | None |
| 12b-1 fee | 0.25% | 0% |
| 1-yr return | +25.5% | +18.7% |
| 5-yr return (annualized) | +14.2% | +11.3% |
| 10-yr return (annualized) | +10.0% | +10.2% |
| Best quarter | — | +19.6% |
| Worst quarter | — | −21.1% |
| Net assets (fund) | $82.2M | $8.1B |
| Number of holdings | 69 | 1,329 |
| Portfolio turnover | 31% | 2% |
| Returns as of | Dec 31, 2025 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
BGEAX and URTH share none of their top holdings.
BGEAX top 10
- Taiwan Semiconductor Manu — 2.88%
- Gsk Plc — 2.58%
- Sap Se — 2.49%
- Becton Dickinson & Co — 2.35%
- Sanofi Sa — 2.32%
- Erste Group Bank Ag — 2.27%
- Cigna Group/the — 2.27%
- Samsung Electronics Co N/ — 2.25%
- Textron Inc — 2.23%
- Ubs Group Ag Usd0.10 (reg — 2.15%
URTH top 10
- Nvidia Corporation — 5.62%
- Apple Inc. — 5.03%
- Microsoft Corporation — 3.49%
- Amazon.com, Inc. — 2.85%
- Alphabet Inc. — 2.43%
- Broadcom Inc. — 2.21%
- Alphabet Inc. — 2.01%
- Meta Platforms, Inc. — 1.51%
- Tesla, Inc. — 1.35%
- Micron Technology, Inc. — 1.20%
FAQ
What is the difference between BGEAX and URTH?
Which is cheaper, BGEAX or URTH?
Should I own both BGEAX and URTH?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.